249 related articles for article (PubMed ID: 8225679)
1. Cutaneous and ocular changes associated with the use of chlorpromazine.
Wolf ME; Richer S; Berk MA; Mosnaim AD
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
[TBL] [Abstract][Full Text] [Related]
2. Ocular complications of chlorpromazine therapy.
Petrohelos MA; Tricoulis D
Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
[No Abstract] [Full Text] [Related]
3. Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM
Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137
[TBL] [Abstract][Full Text] [Related]
4. Ocular complications of phenothiazines.
Mathalone MB
Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
[No Abstract] [Full Text] [Related]
5. Relation of graded ocular anterior chamber pigmentation to phenothiazine intake in schizophrenics--quantification procedures.
Thaler JS; Curinga R; Kiracofe G
Am J Optom Physiol Opt; 1985 Sep; 62(9):600-4. PubMed ID: 4050962
[TBL] [Abstract][Full Text] [Related]
6. [Ophthalmologic manifestations, with or without associated skin disorders, during prolonged treatment with chlorpromazine].
Baron JB; Morel P; Rivoallan Y; Soulairac A
Agressologie; 1968; 9(2):293-304. PubMed ID: 5675496
[No Abstract] [Full Text] [Related]
7. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
[TBL] [Abstract][Full Text] [Related]
8. [Ocular and cutaneous changes in patients exposed to prolonged treatment with neuroleptic drugs].
Francesconi G; Di Tizio A; Cameo D
Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):835-52. PubMed ID: 4236709
[No Abstract] [Full Text] [Related]
9. Ocular effects of phenothiazine derivatives and reversibility.
Mathalone MB
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
[No Abstract] [Full Text] [Related]
10. Asymmetric anterior segment changes induced by chlorpromazine.
Deluise VP; Flynn JT
Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636
[TBL] [Abstract][Full Text] [Related]
11. [Synthetic antimalarials and skin].
Ribrioux A
Ann Dermatol Venereol; 1990; 117(12):975-90. PubMed ID: 2150584
[No Abstract] [Full Text] [Related]
12. An electron microscopic study of chlorpromazine pigmentation.
Hashimoto K; Wiener W; Albert J; Nelson RG
J Invest Dermatol; 1966 Oct; 47(4):296-306. PubMed ID: 5954160
[No Abstract] [Full Text] [Related]
13. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
Gol'dovskaia IL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
[No Abstract] [Full Text] [Related]
14. Ocular complications related to phenothiazines.
Siddall JR
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:10-3. PubMed ID: 4876740
[No Abstract] [Full Text] [Related]
15. Unusual complications of antipsychotic drugs.
Diamond JM; Santos AB
Am Fam Physician; 1982 Oct; 26(4):153-7. PubMed ID: 6127024
[TBL] [Abstract][Full Text] [Related]
16. Ocular complications of chlorpromazine therapy.
Petrohelos MA; Tricoulis D
Ophthalmologica; 1969; 159(1):31-8. PubMed ID: 4984273
[No Abstract] [Full Text] [Related]
17. [Persistence of bilateral pigmentary deposits in stromal cornea in a woman after a brief treatment with antidepressants].
Panzitt M; Simon M; Weger M
Klin Monbl Augenheilkd; 2001 Apr; 218(4):273-5. PubMed ID: 11392274
[TBL] [Abstract][Full Text] [Related]
18. Blue skin pigmentation and chlorpromazine.
Haddad RI
J Ky Med Assoc; 1977 Mar; 75(3):124-6. PubMed ID: 839129
[No Abstract] [Full Text] [Related]
19. The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population.
Alexander LJ; Bowerman L; Thompson LR
J Am Optom Assoc; 1985 Nov; 56(11):872-6. PubMed ID: 4078212
[TBL] [Abstract][Full Text] [Related]
20. [Ophthalmologic study of patients receiving psychotropic drugs].
Gol'dovskaia IL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
